Physician profile
David Kevin Lyons
NPI 1194131474
$7,651.22
in general payments reported to CMS, 2019-2025
9 companies · $1,144 in 2025
The $1,144 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2021: $626 · 2022: $3,754 · 2023: $1,831 · 2024: $157 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,192 · Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,191.61 |
| Food and Beverage | $941.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,932.59 | 2022-2025 | |
| Medwest Associates | $1,434.81 | 2022-2023 | |
| Stryker Corporation | $1,154.61 | 2019-2024 | Mako, Na, Variax |
| Zimmer Biomet Holdings, INC. | $1,060.28 | 2019-2022 | |
| Zak Ortho | $826.37 | 2025 | |
| Depuy Synthes Sales INC. | $145.39 | 2021-2022 | |
| Acumed LLC | $46.42 | 2024 | Acumed |
| Orthopediatrics Corp. | $30.90 | 2024 | |
| Ethicon US, LLC | $19.85 | 2025 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.